Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

Conditions

• Cancer

Interventions

• OTHER: Statement communicating uncertainty with a single arm trial
• OTHER: Statement communicating uncertainty with limited study duration
• OTHER: Statement communicating uncertainty with a limited study population
• OTHER: Statement communicating uncertainty with an unvalidated surrogate endpoint
• OTHER: Statement communicating uncertainty with treatment effect size

Sponsor

London School of Economics and Political Science

Collaborators

• [object Object]